Search research articles
Contact Us
Filters
Showing results (1-10 of 21) with videos related to
Page
of 3
Sort By:
Cancer Metastasis Reviews
|
October 27, 2017
The ubiquitin-proteasome pathway in adult and pediatric brain tumors: biological insights and therapeutic opportunities
Wafik Zaky, Christa Manton, Claudia P Miller, et al.
Journal of Biomedicine & Biotechnology
|
July 19, 2011
Therapeutic strategies to enhance the anticancer efficacy of histone deacetylase inhibitors
Claudia P Miller, Melissa M Singh, Nilsa Rivera-Del Valle, et al.
Blood
|
February 3, 2009
Caspase-8 dependent histone acetylation by a novel proteasome inhibitor, NPI-0052: a mechanism for synergy in leukemia cells
Claudia P Miller, Sharmistha Rudra, Michael J Keating, et al.
European Journal of Cancer (Oxford, England : 1990)
|
November 3, 2004
Different signalling pathways regulate VEGF and IL-8 expression in breast cancer: implications for therapy
Dina Chelouche-Lev, Claudia P Miller, Carmen Tellez, et al.
Blood
|
March 16, 2007
NPI-0052, a novel proteasome inhibitor, induces caspase-8 and ROS-dependent apoptosis alone and in combination with HDAC inhibitors in leukemia cells
Claudia P Miller, Kechen Ban, Melanie E Dujka, et al.
Chemico-Biological Interactions
|
August 26, 2011
Specific and prolonged proteasome inhibition dictates apoptosis induction by marizomib and its analogs
Claudia P Miller, Christa A Manton, Randal Hale, et al.
International Journal of Cell Biology
|
February 11, 2010
PCI-24781, a Novel Hydroxamic Acid HDAC Inhibitor, Exerts Cytotoxicity and Histone Alterations via Caspase-8 and FADD in Leukemia Cells
Nilsa Rivera-Del Valle, Shan Gao, Claudia P Miller, et al.
Plos One
|
August 13, 2013
Small molecule ErbB inhibitors decrease proliferative signaling and promote apoptosis in philadelphia chromosome-positive acute lymphoblastic leukemia
Mary E Irwin, Laura D Nelson, Janice M Santiago-O'Farrill, et al.
Cancer Research
|
June 5, 2016
Definition of a Novel Feed-Forward Mechanism for Glycolysis-HIF1α Signaling in Hypoxic Tumors Highlights Aldolase A as a Therapeutic Target
Geoffrey Grandjean, Petrus R de Jong, Brian James, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 26, 2026
FDA Approval Summary: Tarlatamab for the Treatment of Extensive Stage Small Cell Lung Cancer
Yufan Liu, Jeannette Nashed, Amy K Barone, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 21) with videos related to
Sort By:
Page
of 3
Cancer Metastasis Reviews
|
October 27, 2017
The ubiquitin-proteasome pathway in adult and pediatric brain tumors: biological insights and therapeutic opportunities
Wafik Zaky, Christa Manton, Claudia P Miller, et al.
Journal of Biomedicine & Biotechnology
|
July 19, 2011
Therapeutic strategies to enhance the anticancer efficacy of histone deacetylase inhibitors
Claudia P Miller, Melissa M Singh, Nilsa Rivera-Del Valle, et al.
Blood
|
February 3, 2009
Caspase-8 dependent histone acetylation by a novel proteasome inhibitor, NPI-0052: a mechanism for synergy in leukemia cells
Claudia P Miller, Sharmistha Rudra, Michael J Keating, et al.
European Journal of Cancer (Oxford, England : 1990)
|
November 3, 2004
Different signalling pathways regulate VEGF and IL-8 expression in breast cancer: implications for therapy
Dina Chelouche-Lev, Claudia P Miller, Carmen Tellez, et al.
Blood
|
March 16, 2007
NPI-0052, a novel proteasome inhibitor, induces caspase-8 and ROS-dependent apoptosis alone and in combination with HDAC inhibitors in leukemia cells
Claudia P Miller, Kechen Ban, Melanie E Dujka, et al.
Chemico-Biological Interactions
|
August 26, 2011
Specific and prolonged proteasome inhibition dictates apoptosis induction by marizomib and its analogs
Claudia P Miller, Christa A Manton, Randal Hale, et al.
International Journal of Cell Biology
|
February 11, 2010
PCI-24781, a Novel Hydroxamic Acid HDAC Inhibitor, Exerts Cytotoxicity and Histone Alterations via Caspase-8 and FADD in Leukemia Cells
Nilsa Rivera-Del Valle, Shan Gao, Claudia P Miller, et al.
Plos One
|
August 13, 2013
Small molecule ErbB inhibitors decrease proliferative signaling and promote apoptosis in philadelphia chromosome-positive acute lymphoblastic leukemia
Mary E Irwin, Laura D Nelson, Janice M Santiago-O'Farrill, et al.
Cancer Research
|
June 5, 2016
Definition of a Novel Feed-Forward Mechanism for Glycolysis-HIF1α Signaling in Hypoxic Tumors Highlights Aldolase A as a Therapeutic Target
Geoffrey Grandjean, Petrus R de Jong, Brian James, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 26, 2026
FDA Approval Summary: Tarlatamab for the Treatment of Extensive Stage Small Cell Lung Cancer
Yufan Liu, Jeannette Nashed, Amy K Barone, et al.
Page
of 3